Clinical Supply Management Articles

  1. What CAPAs Don't Catch: 3 Hidden ATMP Cold Chain Vulnerabilities By Design 4/10/2026

    Cold chain failures in ATMPs often stem from hidden design flaws, not execution errors. Learn how overlooked material, process, and preservation choices drive risk.

  2. AI And Digital Tools Advance Clinical Trial Supply Chains 4/9/2026

    AI is reshaping trial supply with smarter forecasting, risk detection, and real-time control, cutting waste, preventing delays, and turning data into decisive action.

  3. The Hidden Bottleneck: Clinical Supply Strategy In Study Start-Up 4/7/2026

    Delays in clinical trials often hide in late supply planning. Early integration of supply strategy ensures product availability, reduces risk, and keeps studies on schedule.

  4. Why More Tools Won't Fix Clinical Supply 4/6/2026

    Clinical supply fails when tools outpace the operating model. Clear workflows, governance, trusted records, and adoption strategies create scalable, reliable supply.

  5. The Hidden Supply Chain Risks That Can Derail Small Biotech Trials 4/3/2026

    Small biotech trials face hidden supply risks that waste up to 75% of materials, delay timelines, and drain funding faster. Learn what causes them and how to prevent them.

  6. The RTSM–EDC Integration Trap: Why Broken Workflows Still Undermine Trial Execution 3/31/2026

    Broken RTSM–EDC integrations keep clinical trials stalled with blocked randomizations, kit errors, and endless reconciliations. Here’s how to fix workflows before tech fails.

  7. Building Win-Win Partnerships In Clinical Trial Supply 3/30/2026

    Strong supplier partnerships are the backbone of reliable clinical trial supply, driving speed, flexibility, and better outcomes through trust, transparency, and shared goals.

  8. The NDC-12 Ripple Effect: Why Clinical Trial Supply Chains Must Act Seven Years Early 3/30/2026

    Clinical trial supply chains face a 2033 NDC-12 deadline; early action on product identity, labeling, and data governance can prevent costly disruptions and misalignment.

  9. The New Reality Of Clinical Trial Logistics 3/26/2026

    Small, high-value shipments are reshaping clinical trial logistics, increasing risk and complexity while forcing supply teams to rethink strategy, visibility, and control.

  10. Drug Shortages In Clinical Trials: A Policy Blueprint 3/26/2026

    Clinical trial drug shortages are a silent crisis threatening patient safety, trial integrity, and costs. Practical policy reforms and risk planning can prevent disruption.